Abuse Deterrence
Building Guardrails, Not Just Pills: Rethinking Pain Management without Abuse
David Alvaro, Ph.D.; Paul Howe
Pharma's Almanac
PAO-06-25-CL-11Jun 24, 2025
Opioids
Analysis of Government Data Reveals Main Players in Opioid Market
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-013Aug 07, 2019
Opioids
Statement on FDA’s Request for Information on Requiring Fixed-Quantity Blister Packaging for Certain Opioid Pain Medicines
PR-M06-19-NI-003Jun 05, 2019
Opioids
Top Execs at Opioid Maker Insys Therapeutics Found Guilty of Paying Bribes
Nice Insight
PAO-M05-19-NI-015May 10, 2019
Partnership
Heron Therapeutics Partners with the National Academy of Medicine to Counter the Opioid Epidemic in the United States
Heron Therapeutics, Inc.
PR-M05-19-NI-027May 09, 2019
FDA Statement
FDA Statement on New Opioid Analgesic Labeling Changes
U.S. Food & Drug Administration
PR-M04-19-NI-042Apr 12, 2019
Opioids
Generic Suboxone Sublingual Film Launched
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-004Mar 05, 2019
Opioids
Statement from FDA Commissioner Scott Gottlieb, M.D. on the Agency's 2019 policy and Regulatory Agenda for Continued Action to Forcefully Address Opioid Abuse
U.S. Food & Drug Administration
PR-M02-19-NI-061Feb 27, 2019
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on Ongoing Efforts to Secure the U.S. Supply Chain and Confront the Opioid Epidemic
U.S. Food & Drug Administration
PR-M02-19-NI-032Feb 14, 2019
Opioids
New Study Shows Physician-Targeted Marketing is Associated with Increase in Opioid Overdose Deaths
NYU Langone Health
PR-M01-19-NI-063Jan 22, 2019
Opioid Dependency
Could the Opioid Epidemic Be Relieved by a Vaccine?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-019Dec 19, 2018
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on Agency's Approval of Dsuvia and the FDA's Future Consideration of New Opioids
U.S. Food & Drug Administration
PR-M11-18-NI-016Nov 05, 2018
Opioids
HBI Solutions' Tool Predicts Who Is Likely to Abuse Opioids Using Medical and Social Data
HBI Solutions
PR-M07-18-NI-064Jul 19, 2018
Opioids
Gottlieb Discusses Results of Online Opioid Summit
Emilie Branch
Pharma's Almanac
PAO-M07-18-NI-003Jul 10, 2018
Opiods
Preliminary Data Suggests DENKI Pain Blockers Don’t Have Abuse Potential
Emilie Branch
Pharma's Almanac
PAO-M06-18-NI-008Jun 12, 2018
Abuse Deterrence
Generic Firms Developing Opioids with Abuse-Deterrent Properties Have New FDA Guidance to Follow
Emilie Branch
Pharma's Almanac
PAO-M12-17-NI-012Dec 08, 2017
Innovation
Study Reveals New Medication Options for Opioid Dependency
Nice Insight
PAO-M11-17-NI-040Nov 23, 2017
Non-Opioid
SiteOne Therapeutics Garners US Department of Defense Award
Emilie Branch
Pharma's Almanac
PAO-M11-17-NI-036Nov 21, 2017
Information Technology
Fighting Opioid Abuse, Axial Healthcare Rolls Out New IT-based Care Platform
Guy Tiene
Nice Insight
PAO-M10-17-NI-034Oct 24, 2017
Abuse Deterrence
Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations
Angela Moore, M.Sc.
Alcami
PAP-Q3-17-CL-003Sep 15, 2017